Private Equity

Updated:

Sears Capital Management

Sears Capital Management, Inc. is a venture investment and portfolio management firm founded in 1994. It specializes in life sciences, focusing on...

Sears Capital Management logo

Sears Capital Management

Sears Capital Management, Inc. is a venture investment and portfolio management firm founded in 1994. It specializes in life sciences, focusing on pharmaceuticals and medical devices. The firm manages affiliated funds that provide seed capital and early stage financing for life science companies and startups.

General information

Firm type

Private Equity

Year founded

1994

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Cupertino

Corporate office

Cupertino, CA, United States

Sector focus

Life SciencesHealthcare Services

Frequently asked questions

What is Sears Capital Management's current investment posture?

The firm has publicly stated it is no longer investing in new ventures. It continues to manage its existing portfolio of life science companies but is not making new seed or early-stage commitments.

What stage did Sears Capital Management typically target?

The firm specialized in company creation — helping found life science startups — and providing seed and early-stage financing. It did not participate in later-stage growth or crossover rounds.

Which sectors did Sears Capital Management focus on?

The firm concentrated exclusively on life sciences, including therapeutics, diagnostics, and enabling platform technologies. It maintained this narrow focus throughout its three decades of activity.

How many companies did Sears Capital Management back?

According to the firm, Sears Capital Management and its affiliated funds provided seed and early-stage financing to more than 50 life science companies and startups since its founding in 1994.

Is Sears Capital Management raising new funds?

There is no public indication of new fundraising. The firm's website states plainly that it is no longer investing in new ventures, which implies no active fundraise.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Cupertino Private Equity profiles